Promise for patients with metastatic renal cell carcinoma
- PMID: 17287864
- DOI: 10.1038/ncpuro0704
Promise for patients with metastatic renal cell carcinoma
Comment on
-
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.J Clin Oncol. 2006 Jun 1;24(16):2505-12. doi: 10.1200/JCO.2005.03.6723. Epub 2006 Apr 24. J Clin Oncol. 2006. PMID: 16636341 Clinical Trial.
Similar articles
-
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.J Urol. 2007 Nov;178(5):1896-900. doi: 10.1016/j.juro.2007.07.037. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868729
-
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.J Urol. 2008 May;179(5):1719-26. doi: 10.1016/j.juro.2008.01.018. Epub 2008 Mar 17. J Urol. 2008. PMID: 18343437
-
Cytoreductive nephrectomy in metastatic renal cell carcinoma.Curr Opin Urol. 2008 Sep;18(5):474-80. doi: 10.1097/MOU.0b013e32830a4f21. Curr Opin Urol. 2008. PMID: 18670270 Review.
-
Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome.JOP. 2009 Jul 6;10(4):413-8. JOP. 2009. PMID: 19581746 Review.
-
Debulking nephrectomy followed by a "watch and wait" approach in metastatic renal cell carcinoma.Urol Oncol. 2009 Mar-Apr;27(2):149-54. doi: 10.1016/j.urolonc.2007.10.017. Epub 2008 Apr 24. Urol Oncol. 2009. PMID: 18439851
Publication types
LinkOut - more resources
Full Text Sources